Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Activin B helps start and grow hair follicles in mice.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Higher cholesterol levels increase aggressive prostate cancer risk.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Tamoxifen caused hair loss in a 52-year-old woman.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Women who had cancer treatment feel both positive and negative about their bodies.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.